Deep lobe parotid tumors which are located deep to the facial nerve are rare. If you have a deep lobe tumor make sure your surgeon has extensive experience treating these tumors. The “deep lobe” of the parotid gland makes up a variable amount of salivary gland tissue lying deep to the facial nerve. Approximately 10% of parotid tumors arise from the “deep lobe”, with a small proportion of these developing extensions around the jaw bone and into the deep spaces of the neck lying adjacent to the pharynx or throat. When deep lobe tumors extend beyond the confines of the parotid capsule, they encroach on other important neck structures beyond the facial nerve. These important structures may include the carotid artery, jugular vein, lingual nerve, vagus nerve, and glossopharyngeal nerve. Because of the complexity of structures in and around the space occupied by the tumor, these cases present a greater surgical challenge. Dr. Osborne has extensive experience treating superficial and deep lobe parotid tumors. Diagnosis of deep lobe tumors may be elusive because of their hidden location.
Deep-lobe parotid tumor presenting in the parapharyngeal space
by Sofia Avitia, MD, Jason S. Hamilton, MD, and Ryan F. Osborne, MD, FACS
A 31-year-old man presented with an oral mass that had become progressively larger over the previous several months. He denied any odynophagia, dysphagia, otalgia, weight loss, or respiratory distress. On intraoral examination, the patient was noted to have a left-sided submucosal mass that involved the left oropharynx (figure 1). On nasal endoscopy, submucosal fullness was seen in the left nasopharynx; on laryngoscopy, the left oropharyngeal fullness was seen extending to the hypopharynx. However, the true vocal folds were mobile bilaterally, and the airway remained patent. Magnetic resonance imaging (MRI) of the neck revealed a left-sided 6.8-cm parapharyngeal space (PPS) mass (figure 2). No fat tissue plane was seen between the deep lobe of the left parotid gland and the mass. Radiographically, this finding was consistent with the presence of a deep-lobe parotid tumor.
Parotidectomy is the removal of part of the greater part of the parotid gland on one side of the face.
Understanding the anatomy of the facial nerve (as it identifies with the parotid organ) is crucial to understand the medical procedure.
This procedure is performed to remove parotid cancer, which is cancer of the salivary gland.
Contact us at Healing Touristry for Best Doctors of Parotidectomy Surgery in India.
Global salivary gland infection market information, by diagnosis (plain radiography, sialography, and others), by treatment (medication, surgery, aspiration, and others), by end user- Forecast till 2027Global salivary gland infection market.
The Global Salivary Gland Infection Market is growing continuously and expected to grow at a CAGR of 6.7% from 2017 to 2023Taste the market data and market information presented through more than 61 market data tables and figures spread over 76 pages of the project report.
Avail the in-depth table of content TOC & market synopsis on “Salivary Gland Infection Market Research Report –Global Forecast to 2023.”Market HighlightsThe global salivary gland infection market has been evaluated as a moderately growing market and it is expected to continue growing in the near future.
Some other factors such as changing disease patterns, smoking, and changing environment are driving the growth of global salivary gland infection market.The market for salivary gland infection was around USD 2300.8 million in 2016 and is expected to reach USD 3622.6 million which is projected to grow at a CAGR of 6.7% by 2023.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/3779Major players in Salivary Gland Infection market:There are plenty of large and small market players which operate in this market: AbbVie Inc. (US), Allergan (Republic of Ireland), AstraZeneca (UK), FUJIFILM Holdings Corporation (Japan), General Electric Company (US), GlaxoSmithKline plc.
Drug manufactures are investing large amount of money in new product development as well as improvement of existing product to derive efficient solution for market.
US is dominating and top revenue generator in Americas market that is mainly due to some factors like increasing investment research and clinical trials.
